Procathepsin B Fragments

Online Inquiry
Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
CAT# Product Name M.W Molecular Formula Inquiry
P12001 Procathepsin B (26-50) (rat) 2713.20 C123H198N34O33S Inquiry
P12002 Procathepsin B (36-50) (rat) 1562.94 C71H123N19O18S Inquiry

Introduction

Procathepsin B is a 339 amino acid polypeptide with a molecular weight of approximately 40-45 kD, which is an important substance involved in the production of cathepsin B. Procathepsin B is released to the cytoplasm, and an N-terminal glycosylation site is synthesized in the rough endoplasmic reticulum and glycosylated, and the glycosyl group is further phosphorylated in the Golgi to form mannose-6-phosphoprotein. It is recognized by lysosomal mannose receptors (MPRR) and then sorbent lysosomes and activated by themselves or other proteases. Procathepsin B is proteolytically cleaved into a mature single-stranded active form of 30 kD, which is further cleaved, including removal of the N-terminal propeptide, removal of the 6-amino acid residue at the C-terminus, and internal 127th and 128th amino acid residues. Inter-cutting, the formation of active mature cathepsin B is finally formed.

Mechanism of action

In tumor tissues, the expression of procathepsin B is greatly increased. The cathepsin B secreted by tumor cells lacks the mannose-6-phosphate receptor recognition marker and cannot be taken up by lysosomes, but often in the form of zymogens in the cytosol and extracellular. Procathepsin B has no malignant potential, only mature cathepsin B is involved in tumor invasion and metastasis, but procathepsin B binds to the surface of tumor cells via p11 (the light chain of annexin II heterotetramer), this combination of PB seems to promote tumor invasion and metastasis.

Application of Procathepsin B Fragments

A significant difference (p < 0.05) in serum procathepsin B was noted between cancer and benign tumors, which can be used for differential diagnosis between malignant and benign tumors as a new tumor biomarker. Procathepsin B is highly expressed in tumor tissues and can be used as a marker for tumor organisms for detection, and the expression of procathepsin B differs between benign tumors and malignant tumors and thus can be used to determine tumor type. The binding process of cathepsin B to tumors can affect tumor invasion and metastasis, so it can be used as a target for treating tumors.

References

  1. Gashenko, E. A., Lebedeva, V. A., Brak, I. V., Tsykalenko, E. A., Vinokurova, G. V., & Korolenko, T. A. (2013). Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer. International journal of circumpolar health, 72(1), 21215.
  2. Caglic, D., Pungercar, J. R., Pejler, G., Turk, V., & Turk, B. (2007). Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. Journal of Biological Chemistry.
Quick Inquiry
×
Get in touch with us

USA

Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA

Tel: 1-631-624-4882

Fax: 1-631-614-7828

Email: info@creative-peptides.com

 

Germany

Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main

Email: info@creative-peptides.com

Copyright © 2025 Creative Peptides. All rights reserved.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x